Karen McLaren jokes around with her six-year-old nephew. McLaren who has stage 4 breast cancer has been fighting to get a life-saving drug covered in B.C. Coverage is now available, but only to a select few, not including her. Submitted photo

No celebrating cancer drug coverage, says B.C. woman

BC Cancer Agency approves potentially life-saving drug Ibrance but severely restricts access

It should have been a time for celebration for Langley resident Karen McLaren, following all her work to get the cancer fighting drug Ibrance covered for women with metastatic breast cancer.

On April 1, the B.C. Cancer Agency announced it will cover the costs of a potentially life-saving drug Ibrance. The drug specifically works well for women with advanced breast cancer, stopping the disease from spreading or growing. For some, it can even put the person in remission.

But McLaren isn’t celebrating.

While the BC Cancer Agency has added the drug to its registry, the restrictions on which patients will be eligible to receive it are so limited in scope that almost no person will qualify, said McLaren.

Women can’t even be considered unless they are post-menopausal.

McLaren is only 42 years old.

“I am disappointed that the BC Cancer Agency chose to add this caveat to their coverage. This means that hundreds of women and men in B.C. will not be covered for Ibrance. This limits almost everyone’s access to this life prolonging drug,” McLaren told the Times.

It’s a troubling blow for McLaren, who has been paying out of pocket $8,000 a month to get the daily pill.

“Their statement ‘post-menopausal women with ER-positive, HER2- negative advance breast cancer with no prior systemic treatment (including chemotherapy) for metastatic disease,’ excludes me and all the other patients who have been treated with any other approved treatments,” she said.

“So while Ibrance has been tied up in the bureaucratic system of approval, many of us have undergone treatments, which now (place) us outside the parameters of their conditions.”

Dr. Helen Anderson, the provincial lead for Systemic Therapy at BC Cancer Agency said she doesn’t believe there is enough evidence at this time to fund Ibrance for patients outside the strict parameters.

Ibrance has been approved for first line treatment of post-menopausal, ER positive, HER2 negative metastatic breast cancer.

“This is the setting where there is good evidence of a benefit for patients, and where Ibrance has shown the most impact in the treatment of this type of cancer,” writes Anderson.

“This is also the indication approved by Health Canada, requested by clinicians across the country and reviewed and recommended for funding by the National and Provincial Health Technology review bodies.

“There is not enough evidence at this time to fund Ibrance outside of the approved indication. However, a number of other effective treatments with proven benefit are available for metastatic breast cancer patients.”

She didn’t indicate what those treatments are beyond the traditional mastectomy, chemotherapy and radiation.

It was McLaren’s oncologist who recommended Ibrance.

As previously reported, McLaren’s friend Ashley, who is the same age and had advanced breast cancer. is now in remission after being treated with Ibrance. Ashley, who lives in Maple Ridge, works for an American company whose health insurance covers the cost of Ibrance fully.

READ: Potentially life-saving drug Ibrance costs $8,000 per month

A petition McLaren’s sister started on Change.org and sent to the provincial Ministry of Health and Health Canada to fund Ibrance for all breast cancer patients received more than 5,000 signatures.

The fight to get coverage continues, said McLaren.

McLaren has had a long battle with cancer. The former model was in her early 30s when she was diagnosed with breast cancer. McLaren had a mastectomy and spent months undergoing chemotherapy.

She thought she had kicked cancer and started to return to her life. But the disease returned nearly 10 years later, in 2014, having metastasized into her lung.

READ: This is the face of cancer

She has been taking Ibrance for a couple months now but doesn’t know just yet if it is working for her.

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Ride For Doug Muscular Dystrophy fundraiser to proceed

It will be shorter and much of it will be online due to COVID-19 restrictions

Abbotsford football star Samwel Uko dies at age 20

Panthers star running back dies on May 21, cause of death not yet known

LETTER: Angels come to aid of elderly couple in distress

In the craziness of the moment, letter writer forgot to get names, and is anxious to say thanks

A second wave of COVID-19 is probable, if history tells us anything

B.C.’s top doctor says that what health officials have learned this round will guide response in future

LIVE: Procession to honour Snowbirds Capt. Jennifer Casey comes to Halifax

Snowbirds service member died in a crash in Kamloops one week ago

Facing changes together: Your community, your journalists

Thanks for helping the Aldergrove Star to continue its mission to provide trusted local news

RCMP facing ‘systemic sustainability challenges’ due to provincial policing role

Provinces, territories and municipalities pay anywhere from 70 to 90 per cent of the cost of the RCMP’s services

‘Not a joke’: Promoter wants to rocket-launch man the length of White Rock pier

Brooke Colby says he’s building an eight-foot rocket in his backyard

One man dead after standoff with Chilliwack RCMP

The Independent Investigations Office of B.C. is investigating the RCMP’s role in the death

B.C. employers worry about safety, cash flow, second wave in COVID-19 restart

A survey found 75 per cent of businesses worry about attracting customers

Ex-BC Greens leader Andrew Weaver says province came close to early election

Disagreement centred on the LNG Canada project in northern B.C.

Canada’s NHL teams offer options to season-ticket holders

Canadian teams are offering refunds, but also are pushing a number of incentives to let them keep the money

Boy, 2, left with ‘soft tissue injuries’ after being hit by car in Squamish intersection

Boy was release from hospital, police continue to investigate

Most Read